Michael Frank Drummond

Michael Frank Drummond (born 30 April 1948) is a British health economist known for his contributions to the economic evaluation of health care interventions, health technology assessment, and applied health economics. He has held senior academic posts in the United Kingdom, Canada, and Italy, and has served as president of both the International Society of Technology Assessment in Health Care (ISTAHC) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Early life and education Michael Frank Drummond was born on 30 April 1948 and is a British citizen.

Drummond received a B.Sc. (Honours, Class I) in Industrial Metallurgy from the University of Birmingham in 1970, followed by an M.Com. in Business Administration from the same institution in 1972. He completed a D.Phil. in Economics at the University of York in 1983.

Academic career Drummond began his academic career in 1972 as a Lecturer in Public Sector Management at the University of Aston in Birmingham.

In 1983–1984 he was Visiting Associate Professor in the Department of Clinical Epidemiology and Biostatistics at McMaster University in Canada.

Drummond joined the University of York in 1990 as Professor of Health Economics at the Centre for Health Economics (CHE). continued as Professor of Health Economics until 2022 and was appointed Professor Emeritus the same year. and served as Visiting Professor at LSE Health from 2007 to 2014. Since 2008 he has been an Honorary Fellow at the Centre for Research on Health and Social Care Management (CERGAS), Bocconi University, Milan.

Other roles Drummond worked as an engineering trainee at Imperial Metal Industries Ltd between 1966 and 1971. He was Director of OHE Consulting Limited and the Office of Health Economics (OHE) from January 2016 to January 2022. Since 2024, he has been affiliated with Quadrant Health Economics Inc. He also served as Associate Editor of the Journal of Mental Health Policy and Economics from 1996 onwards.

He was President of the International Society of Technology Assessment in Health Care (ISTAHC) from 1997 to 1999, and Past-President from 1999 to 2001; and later served as President (2006–2007) and Past-President (2007–2008) of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). and chaired the NICE Guidelines Review Panel between 2003 and 2012. He also served on the Steering Group for the NICE Methods Review (2020–2022). Drummond was elected a member of the Institute of Medicine (now the National Academy of Medicine) of the United States in 2015.

Research Drummond’s research focuses on the economics of health and health services, with particular emphasis on the economic evaluation of health care interventions and technologies. His work has addressed cost–effectiveness analysis across diverse clinical areas, including neonatal intensive care, cancer diagnostics, digital imaging, pharmaceutical therapy, and eye health care.

A further strand of his work examines how economic analysis can support policy making and management at different levels of the health care system. Drummond is also known for his contributions to teaching and knowledge translation, particularly in communicating health economics principles to clinicians and other non-economists working in the health sector. He has served as consultant on economic evaluation projects for governments and international organisations, including the World Health Organization. The book provides a structured framework for conducting and appraising economic evaluations of health care interventions and has been widely used in postgraduate teaching and professional training in health economics and health technology assessment.

Honours and distinctions Drummond has received several major international awards in recognition of his contributions to health economics and the methodology of economic evaluation. He received the Avedis Donabedian Outcomes Research Lifetime Achievement Award from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in 2004.

He was awarded a Doctor of Science (honoris causa) by City University London in 2008, followed by a Doctorate Honoris Causa from Erasmus University Rotterdam in 2012.

In 2014, he was recognised by the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University during the 15th anniversary of the Cost-Effectiveness Analysis Registry, in acknowledgement of his contributions to cost-effectiveness analysis. He received a Doctor Honoris Causa from the University of Lisbon in 2015.

Selected publications Drummond has authored or co-authored over 600 publications across health economics, health technology assessment, and applied decision sciences. The following is a selection of recent peer-reviewed works: